Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis

Z Li, S Niu, B Guo, T Gao, L Wang, Y Wang… - Cell …, 2020 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) is an acute respiratory infectious disease
caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). COVID‐19 …

[HTML][HTML] Diabetic nephropathy–a review of risk factors, progression, mechanism, and dietary management

V Natesan, SJ Kim - Biomolecules & therapeutics, 2021 - ncbi.nlm.nih.gov
Type 2 diabetes mellitus (T2DM) leads to many health problems like diabetic nephropathy
(DN). One of the key factors for chronic kidney disease and end-stage renal disease (ESRD) …

[HTML][HTML] Human urine-derived stem cells protect against renal ischemia/reperfusion injury in a rat model via exosomal miR-146a-5p which targets IRAK1

X Li, J Liao, X Su, W Li, Z Bi, J Wang, Q Su, H Huang… - Theranostics, 2020 - ncbi.nlm.nih.gov
Rationale: Ischemia/reperfusion injury (IRI) is a major cause of acute kidney injury (AKI) that
is associated with high morbidity and mortality, and for which specific treatments are lacking …

[HTML][HTML] Molecular mechanisms of kidney injury and repair

S Rayego-Mateos, L Marquez-Expósito… - International journal of …, 2022 - mdpi.com
Chronic kidney disease (CKD) will become the fifth global cause of death by 2040, thus
emphasizing the need to better understand the molecular mechanisms of damage and …

Cell therapy strategies for COVID-19: Current approaches and potential applications

MM Zaki, E Lesha, K Said, K Kiaee… - Science …, 2021 - science.org
Coronavirus disease 2019 (COVID-19) continues to burden society worldwide. Despite most
patients having a mild course, severe presentations have limited treatment options. COVID …

[HTML][HTML] Stem/progenitor cell in kidney: characteristics, homing, coordination, and maintenance

J Huang, Y Kong, C Xie, L Zhou - Stem Cell Research & Therapy, 2021 - Springer
Renal failure has a high prevalence and is becoming a public health problem worldwide.
However, the renal replacement therapies such as dialysis are not yet satisfactory for its …

Hnf4a is required for the development of Cdh6-expressing progenitors into proximal tubules in the mouse kidney

SS Marable, E Chung, JS Park - Journal of the American Society of …, 2020 - journals.lww.com
Background Hepatocyte NF 4α (Hnf4a) is a major regulator of renal proximal tubule (PT)
development. In humans, a mutation in HNF4A impairs PT functions and is associated with …

[HTML][HTML] Mesenchymal stem cell derived extracellular vesicles ameliorate kidney injury in aristolochic acid nephropathy

S Kholia, MB Herrera Sanchez, M Cedrino… - Frontiers in cell and …, 2020 - frontiersin.org
Limitations in the current therapeutic strategies for the prevention of progression of chronic
kidney disease (CKD) to end stage renal disease has been a drawback to improving patient …

Mesenchymal stem cell therapy in kidney diseases: potential and challenges

F Chen, NN Chen, C Xia, H Wang, L Shao… - Cell …, 2023 - journals.sagepub.com
Kidney disease (KD) is a life-threatening disease characterized by high morbidity and
mortality in clinical settings, which can be caused by many reasons, and the incidence …

[HTML][HTML] The anti-inflammatory, anti-oxidative, and anti-apoptotic benefits of stem cells in acute ischemic kidney injury

KH Lee, WC Tseng, CY Yang, DC Tarng - International journal of …, 2019 - mdpi.com
Ischemia-reperfusion injury (IRI) plays a significant role in the pathogenesis of acute kidney
injury (AKI). The complicated interaction between injured tubular cells, activated endothelial …